BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mehta A, Blodgett TM. Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep 2011;5:35-41. [PMID: 22470805 DOI: 10.3941/jrcr.v5i7.722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Dondi F, Albano D, Giubbini R, Bertagna F. PET in idiopathic retroperitoneal fibrosis. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00059-4] [Reference Citation Analysis]
2 Nechiporenko AN. Idiopathic retroperitoneal fibrosis (Ormond's disease): clinical picture, diagnosis, and option of surgical treatment. jour 2020. [DOI: 10.51523/2708-6011.2020-17-3-2] [Reference Citation Analysis]
3 Zhao X, Psarianos P, Ghoraie LS, Yip K, Goldstein D, Gilbert R, Witterick I, Pang H, Hussain A, Lee JH, Williams J, Bratman SV, Ailles L, Haibe-Kains B, Liu FF. Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis. Nat Metab 2019;1:147-57. [PMID: 32694814 DOI: 10.1038/s42255-018-0008-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 30.0] [Reference Citation Analysis]
4 Grozdic Milojevic IT, Milojevic B, Sobic-Saranovic DP, Artiko VM. Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review. Rheumatol Int 2018;38:179-87. [PMID: 28840309 DOI: 10.1007/s00296-017-3798-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Jakhlal N, Elghazoui A, Jabbour Y, Karmouni T, Elkhader K, Koutani A, Ibenattya A. Fibrose rétropéritonéale: revue de littérature. Can Urol Assoc J 2017;11:E26-31. [PMID: 28163809 DOI: 10.5489/cuaj.4122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]